Several clinical study results were published this week, while other companies reached distribution deals. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber […]
Renal Alliance Inc.
NxStage expands hemodialysis supply deal
NxStage Medical Inc. (NSDQ:NXTM) expanded a supply deal with Renal Advantage Inc. to include an additional 43 dialysis centers RAI acquired from National Renal Alliance.